Setting the stage: Current state of affairs and major challenges

Clinical Infectious Diseases

Volumn 50, Issue SUPPL. 3, 2010, Pages

  Reynolds, Steven J ^a,b   Quinn, Thomas C ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CD4 LYMPHOCYTE COUNT; EPIDEMIC; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MORTALITY; PANDEMIC; PRIORITY JOURNAL; REVIEW;

AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DEVELOPING COUNTRIES; DISEASE OUTBREAKS; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; TUBERCULOSIS;

EID: 77951856309     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651476     Document Type: Review

References (40)

1. UNAIDS Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic. 2008.
2. Centers for Disease Control and Prevention. Persons tested for HIVUnited States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57(31): 845-849.
3. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300(5):520-529.
4. District of Columbia Department of Health Report on HIV/AIDS, 2008. 2008. http://doh.dc.gov/doh/frames.asp?doc =/doh/lib/doh/pdf/ dc-hiv-aids-2008- updatereport.pdf. Accessed 23 February 2010.
5. Bendavid E, Bhattacharya J. The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes. Ann Intern Med 2009; 150(10):688-695.
6. Celebrating Life: Latest PEPFAR Results. 2008. http://www.pepfar.gov/ documents/organization/112594.pdf. 23 February 2010.
7. Bunnell R, Opio A, Musinguzi J, et al. HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey. AIDS 2008; 22(5):617-624. (Pubitemid 351640594)
8. Brinkhof MW, Boulle A, Weigel R, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med 2009; 6(4):e1000066.
9. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360(18):1815-1826.
10. Keiser O, Anastos K, Schechter M, et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health 2008; 13(7):870-879.
11. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access recommendations for a public health approach. Geneva: World Health Organization, 2006.
12. Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 2008; 22(15):1971-1977.
13. Moore DM, Mermin J, Awor A, Yip B, Hogg RS, Montaner JS. Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings. J Acquir Immune Defic Syndr 2006;43(4):436-1139
14. Reynolds SJ, Nakigozi G, Newell K, et al. Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda. AIDS 2009; 23:1295-1296.
15. Hosseinipour MC, van Oosterhout JJ, Weigel R, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing firstline antiretroviral therapy. AIDS 2009; 23(9): 1127-1134.
16. Mermin J, Were W, Ekwaru JP, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIVuninfected children: a prospective cohort study. Lancet 2008; 371(9614):752-759. (Pubitemid 351297773)
17. Weidle PJ, Wamai N, Solberg P, et al. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 2006; 368(9547):1587-1594. (Pubitemid 44767594)
18. Morris MB, Chapula BT, Chi BH, et al. Use of task-shifting to rapidly scale-up HIV treatment services: experiences from Lusaka, Zambia. BMC Health Serv Res 2009; 9:5.
19. Chang LW, Alamo S, Guma S, et al. Two-year virologie outcomes of an alternative AIDS care model: evaluation of a peer health worker and nurse-staffed community-based program in Uganda. J Acquir Immune Defic Syndr 2009;50(3):276-282.
20. Chang LW, Kagaayi J, Nakigozi G, et al. Responding to the human resource crisis: peer health workers, mobile phones, and HIV care in Rakai, Uganda. AIDS Patient Care STDS 2008; 22:173-174. (Pubitemid 351380162)
21. Chang LW, Kagaayi J, Nakigozi G, et al. Telecommunications and health Care: an HIV/AIDS warmline for communication and consu ltation in Rakai, Uganda. J Int Assoc Physicians AIDS Care (Chic 111) 2008; 7(3):130-132.
22. Skinner D, Rivette U, Bloomberg C. Evaluation of use of cellphones to aid compliance with drug therapy for HIV patients. AIDS Care 2007; 19(5):605-607. (Pubitemid 46763749)
23. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med 2005;2(11):e298.
24. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369(9562):643-656.
25. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369(9562):657-666.
26. Bedri A, Gudetta B, Isehak A, et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008; 372(9635):300-313.
27. Chi BH, Chintu N, Cantrell RA, et al. Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission. J Acquir Immune Defic Syndr 2008; 48(2):220-223.
28. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008; 359(2):119-129.
29. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371(9630):2109-2119. (Pubitemid 351902179)
30. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008;358(15):1560-1571. (Pubitemid 351519816)
31. Celum C, Wald A, Lingappa JR, et al.; Partners in Prevention HSV/ HIV Transmission Study Team. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-1139
32. Lingappa JR, Baeten JM, Wald A, et al.; for the Partners in Prevention HSV/HIV Transmission Study Team. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010 (Epub ahead of print).
33. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342(13) :921-929.
34. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009;23:1397-1404.
35. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373(9657):48-57.
36. Teeraratkul A, Simonds RJ, Asavapiriyanont S, et al. Evaluating programs to prevent mother-to-child HIV transmission in two large Bangkok hospitals, 1999-2001. J Acquir Immune Defic Syndr 2005; 38(2): 208-212.
37. Baral S, Trapence G, Motimedi F, et al. HIV prevalence, risks for HIV infection, and human rights among men who have sex with men (MSM) in Malawi, Namibia, and Botswana. PLoS ONE 2009; 4(3): e4997.
38. Mermin J, Lule J, Ekwaru JP, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004; 364(9443):1428-1434. (Pubitemid 39370718)
39. Lule JR, Mermin J, Ekwaru JP, et al. Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda. Am J Trop Med Hyg 2005; 73(5): 926-933. (Pubitemid 41688470)
40. Price JE, Micomyiza E, Nyeimana V, Tchupo J. Integrating HIV clinical services in primary health care centers in Rwanda: effect on the quantity on non-HIV services delivered. In: Program and abstract of the 2007 HIV/AIDS Implementers Meeting (Kigali, Rwanda). 2007. Abstract 250.